No significant associations have been found between soluble protein levels and clinical benefit response or PFS in pNENs, while high sVEGFR-3 and IL-8 levels correlated with shorter PFS and shorter OS in carcinoid tumors. This evidence concerns the gene CXCL8 and carcinoid tumor.